Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Screening for Urinary Incontinence by Primary Care Providers
A completed clinical trial evaluating screening for urinary incontinence by primary care providers.
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: The Best Parameter of Bladder Diary Correlates With the Volume at Strong Desire to Void of Filling Cystometry
This clinical trial update reports that the best parameter of the bladder diary correlates with the volume at the moment of strong desire to…
-
FDA approval · 2013-01-25FDA Approved: OXYTROL FOR WOMEN — Original Application (Allergan, Inc.)
The FDA approved OXYTROL FOR WOMEN (oxybutynin) under Allergan's original application. It is indicated for urinary symptoms associated with …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Trospium Chloride XR in Obese Female Patients With Overactive Bladder [Phase 4]
Phase 4 clinical trial update on trospium chloride XR in obese women with overactive bladder. The study status is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Lessening Incontinence by Learning Yoga [NA]
A completed UCSF trial evaluated whether learning yoga can lessen urinary incontinence symptoms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-12-03Clinical Trial Update: Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluating solifenacin succinate (VESICARE) for urinary incontinence in Parkinson's disease has been withdrawn.
-
FDA approval · 2012-11-30FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for trospium chloride submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2012-10-10FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's OXYTROL (oxybutynin) supplemental application, enabling a label modification for the product.
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials comparing surgical procedures to reduce urinary stress incontinence, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: TOMUS-Trial Of Mid-Urethral Slings [Phase 4]
Phase 4 trial evaluating mid-urethral sling procedures for urinary incontinence completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: I-STOP TOMS - Trans Obturator Male Sling [Phase 4]
Phase 4 clinical trial update for the I-STOP TOMS transobturator male sling in male urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Bladder Scan of Residual Urine With New Catheter [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating a new catheter for measuring residual urine (bladder scan) in urinary incontinence has completed with …
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder [Phase 2]
Phase 2 study evaluating safety and efficacy of DR-3001 versus placebo in women with overactive bladder has completed.
-
FDA approval · 2012-08-01FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate submitted by Mylan Pharmaceuticals Inc. under NDA 020771. The drug is a tre…
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up
This document reports a 9-year follow-up of Urgent-SQ for the treatment of overactive bladder, focusing on long-term outcomes and safety.
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited.
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride filed by Teva Pharmaceuticals USA, Inc., encompassing a labeling change thro…
-
FDA approval · 2012-05-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for trospium chloride filed by Glenmark Pharmaceuticals Inc., USA, supporting a labeling change …
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Prospective Evaluation of Keat Electrostimulator in the Auto-reeducation of Female Urinary Incontinence
This document reports a completed prospective evaluation of the Keat electrostimulator for auto-reeducation in female urinary incontinence. …
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Mixed Incontinence: Medical Or Surgical Approach? [Phase 4]
Phase 4 clinical trial evaluating medical versus surgical treatment for mixed urinary incontinence was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: InterStim Therapy Programming Study [NA]
Completed clinical trial evaluating InterStim Therapy programming; results were posted in 2012.
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, likely updating labeling or indications.
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited. This action approves the generic pr…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Effect of Pelvic Floor Muscle Training Included in General Fitness Classes During Pregnacy [NA]
A clinical trial evaluating pelvic floor muscle training included in general fitness classes during pregnancy has completed.
-
CLINICAL_TRIALS research · 2012-03-05Clinical Trial Update: Investigation of the Suburothelial Myofibroblast Network and of Smooth Muscle Function and Control in the Human Urinary Outflow Tract
This entry describes an ongoing clinical trial from Ludwig-Maximilians-University Munich. It investigates the suburothelial myofibroblast ne…